Superior Plus Corp (SPB)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 6.830 |
|---|---|
| 52-week range | 6.060 – 8.860 |
| Return, 1 month / 3 months | −5.7% / −15.7% |
| Return, 1 year / 3 years | −12.1% / +6.7% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 42.4% |
| Worst drawdown (1 year) | -21.9% |
| Average daily value traded | 4.59M CAD |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Superior Plus Corp is a Canadian energy distribution company based in Calgary, Alberta. It supplies propane and other refined fuels to residential, commercial and industrial customers, mainly across Canada and the United States. The company also provides related services such as tank installation, delivery and maintenance for homes and businesses that rely on propane for heating, cooking and other uses. Its operations focus on fuel distribution and the customer service that supports it.
On this site Superior Plus Corp appears as a stock on the Toronto Exchange (Canada), code SPB, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Superior Plus Corp (SPB) trades on the Toronto Exchange in Canada. It last closed at CAD 6.830 on 23 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 508 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.1% and over the last three months it fell 15.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.1% | ||
| From 52-week high | -21.5% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.7% | ||
| 6-month return | -7.3% | ||
| 12-month return, skipping the last month | -6.8% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 42.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.9% | ||
| Liquidity | 70 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.59M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 58 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −5.7% |
| 3 months | −15.7% |
| 6 months | −7.3% |
| 1 year | −12.1% |
| 3 years | +6.7% |
| 5 years | +12.8% |
Signals
| 50-day / 200-day average | 7.060 / 7.275 |
|---|---|
| Golden / death cross (60 days) | Death, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.144 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | CAD 0.0450 |
| 30 Jun 2026 | CAD 0.0450 |
| 31 Mar 2026 | CAD 0.0450 |
| 31 Dec 2025 | CAD 0.0450 |
| 29 Sep 2025 | CAD 0.0450 |
| 30 Jun 2025 | CAD 0.0450 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.